| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 300 | 2026 | 775 | 56.800 |
Why?
|
| Blood Vessel Prosthesis Implantation | 283 | 2026 | 744 | 54.570 |
Why?
|
| Aortic Aneurysm, Thoracic | 184 | 2026 | 691 | 40.490 |
Why?
|
| Blood Vessel Prosthesis | 219 | 2026 | 474 | 35.050 |
Why?
|
| Aortic Aneurysm, Abdominal | 156 | 2026 | 369 | 34.760 |
Why?
|
| Stents | 189 | 2026 | 781 | 26.610 |
Why?
|
| Prosthesis Design | 176 | 2026 | 614 | 16.860 |
Why?
|
| Treatment Outcome | 340 | 2026 | 12910 | 8.670 |
Why?
|
| Aortic Aneurysm | 35 | 2025 | 220 | 8.400 |
Why?
|
| Aorta, Thoracic | 33 | 2026 | 529 | 6.800 |
Why?
|
| Postoperative Complications | 127 | 2026 | 3114 | 6.690 |
Why?
|
| Iliac Aneurysm | 22 | 2022 | 30 | 6.610 |
Why?
|
| Time Factors | 201 | 2026 | 6241 | 6.560 |
Why?
|
| Aged, 80 and over | 198 | 2026 | 6784 | 6.020 |
Why?
|
| Aortic Diseases | 22 | 2026 | 189 | 5.980 |
Why?
|
| Risk Factors | 212 | 2026 | 11003 | 5.290 |
Why?
|
| Aged | 284 | 2026 | 20958 | 5.230 |
Why?
|
| Renal Artery | 25 | 2026 | 70 | 5.010 |
Why?
|
| Endoleak | 34 | 2026 | 44 | 4.860 |
Why?
|
| Aortography | 57 | 2026 | 151 | 4.730 |
Why?
|
| Vascular Surgical Procedures | 40 | 2025 | 539 | 4.620 |
Why?
|
| Ischemia | 32 | 2022 | 355 | 4.290 |
Why?
|
| Aortic Rupture | 14 | 2024 | 112 | 4.100 |
Why?
|
| Computed Tomography Angiography | 37 | 2026 | 214 | 3.940 |
Why?
|
| Humans | 437 | 2026 | 130776 | 3.590 |
Why?
|
| Mesenteric Vascular Occlusion | 17 | 2024 | 25 | 3.560 |
Why?
|
| Angioplasty, Balloon | 18 | 2019 | 128 | 3.410 |
Why?
|
| Retrospective Studies | 208 | 2026 | 17674 | 3.390 |
Why?
|
| Aneurysm | 16 | 2023 | 67 | 3.300 |
Why?
|
| Male | 301 | 2026 | 64680 | 3.240 |
Why?
|
| Vascular Patency | 52 | 2025 | 181 | 3.150 |
Why?
|
| Femoral Artery | 21 | 2025 | 136 | 2.790 |
Why?
|
| Female | 285 | 2026 | 70630 | 2.780 |
Why?
|
| Vascular Diseases | 17 | 2021 | 154 | 2.770 |
Why?
|
| Prospective Studies | 54 | 2025 | 6494 | 2.750 |
Why?
|
| Risk Assessment | 91 | 2026 | 3716 | 2.710 |
Why?
|
| Mesenteric Ischemia | 19 | 2024 | 30 | 2.660 |
Why?
|
| Spinal Cord Injuries | 10 | 2023 | 277 | 2.510 |
Why?
|
| Middle Aged | 175 | 2026 | 28499 | 2.410 |
Why?
|
| Aorta, Abdominal | 14 | 2022 | 95 | 2.300 |
Why?
|
| Patient Selection | 32 | 2024 | 722 | 2.160 |
Why?
|
| Saphenous Vein | 11 | 2024 | 49 | 2.140 |
Why?
|
| Mesenteric Artery, Superior | 8 | 2026 | 33 | 2.110 |
Why?
|
| Iliac Artery | 15 | 2024 | 63 | 2.070 |
Why?
|
| Angioplasty | 14 | 2017 | 67 | 2.060 |
Why?
|
| Radiation Exposure | 5 | 2025 | 44 | 2.010 |
Why?
|
| Upper Extremity | 11 | 2025 | 51 | 1.900 |
Why?
|
| Spinal Cord Ischemia | 11 | 2025 | 30 | 1.860 |
Why?
|
| Reoperation | 37 | 2025 | 841 | 1.800 |
Why?
|
| Popliteal Artery | 12 | 2021 | 32 | 1.770 |
Why?
|
| Celiac Artery | 11 | 2026 | 31 | 1.720 |
Why?
|
| Tomography, X-Ray Computed | 47 | 2020 | 2104 | 1.710 |
Why?
|
| Quality of Life | 9 | 2025 | 2089 | 1.690 |
Why?
|
| Kidney | 15 | 2022 | 1285 | 1.670 |
Why?
|
| Graft Occlusion, Vascular | 9 | 2026 | 78 | 1.670 |
Why?
|
| Learning Curve | 4 | 2025 | 57 | 1.660 |
Why?
|
| Catheterization, Peripheral | 7 | 2025 | 127 | 1.460 |
Why?
|
| Mesenteric Arteries | 12 | 2024 | 50 | 1.440 |
Why?
|
| Hospital Mortality | 20 | 2025 | 1073 | 1.430 |
Why?
|
| Kaplan-Meier Estimate | 33 | 2020 | 1076 | 1.370 |
Why?
|
| Radiography, Interventional | 5 | 2025 | 87 | 1.330 |
Why?
|
| Vascular Grafting | 7 | 2021 | 48 | 1.330 |
Why?
|
| Minnesota | 34 | 2021 | 180 | 1.320 |
Why?
|
| Hematoma | 8 | 2022 | 88 | 1.290 |
Why?
|
| Ultrasonography, Doppler, Duplex | 10 | 2023 | 34 | 1.290 |
Why?
|
| Chronic Disease | 23 | 2025 | 1232 | 1.270 |
Why?
|
| Feasibility Studies | 20 | 2025 | 828 | 1.260 |
Why?
|
| Vascular System Injuries | 5 | 2026 | 59 | 1.260 |
Why?
|
| Ulcer | 7 | 2021 | 51 | 1.210 |
Why?
|
| Aorta | 15 | 2026 | 524 | 1.210 |
Why?
|
| Peripheral Arterial Disease | 11 | 2023 | 318 | 1.200 |
Why?
|
| Models, Cardiovascular | 3 | 2026 | 166 | 1.200 |
Why?
|
| Embolization, Therapeutic | 11 | 2023 | 226 | 1.200 |
Why?
|
| Carotid Stenosis | 8 | 2018 | 108 | 1.190 |
Why?
|
| Arterial Occlusive Diseases | 7 | 2021 | 100 | 1.150 |
Why?
|
| Surgeons | 2 | 2024 | 286 | 1.140 |
Why?
|
| Renal Artery Obstruction | 7 | 2022 | 38 | 1.090 |
Why?
|
| Clinical Decision-Making | 5 | 2020 | 314 | 1.090 |
Why?
|
| Cone-Beam Computed Tomography | 4 | 2020 | 29 | 1.090 |
Why?
|
| Blood Loss, Surgical | 5 | 2020 | 169 | 1.090 |
Why?
|
| Radiation Dosage | 4 | 2025 | 136 | 1.050 |
Why?
|
| Endarterectomy, Carotid | 8 | 2018 | 77 | 1.040 |
Why?
|
| Clinical Competence | 3 | 2025 | 1055 | 1.030 |
Why?
|
| Pelvis | 4 | 2019 | 68 | 1.030 |
Why?
|
| Patient-Specific Modeling | 2 | 2026 | 11 | 1.000 |
Why?
|
| Retreatment | 14 | 2021 | 87 | 0.970 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2022 | 851 | 0.950 |
Why?
|
| Terminology as Topic | 3 | 2020 | 226 | 0.950 |
Why?
|
| Aneurysm, False | 4 | 2024 | 85 | 0.950 |
Why?
|
| Occupational Exposure | 2 | 2025 | 137 | 0.950 |
Why?
|
| United States | 50 | 2025 | 11834 | 0.940 |
Why?
|
| Glomerular Filtration Rate | 6 | 2021 | 567 | 0.910 |
Why?
|
| Occupational Health | 1 | 2025 | 47 | 0.890 |
Why?
|
| Printing, Three-Dimensional | 3 | 2022 | 87 | 0.860 |
Why?
|
| Lens, Crystalline | 1 | 2025 | 104 | 0.860 |
Why?
|
| Hemodynamics | 3 | 2026 | 812 | 0.840 |
Why?
|
| Subclavian Artery | 6 | 2022 | 65 | 0.830 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2024 | 69 | 0.830 |
Why?
|
| Brachial Artery | 3 | 2020 | 35 | 0.820 |
Why?
|
| Viscera | 4 | 2015 | 55 | 0.820 |
Why?
|
| Prosthesis-Related Infections | 5 | 2013 | 184 | 0.810 |
Why?
|
| Ehlers-Danlos Syndrome | 5 | 2019 | 51 | 0.810 |
Why?
|
| Drainage | 5 | 2025 | 249 | 0.800 |
Why?
|
| Arteries | 8 | 2023 | 208 | 0.790 |
Why?
|
| Loeys-Dietz Syndrome | 2 | 2023 | 43 | 0.780 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2022 | 50 | 0.770 |
Why?
|
| Wounds, Nonpenetrating | 4 | 2026 | 214 | 0.770 |
Why?
|
| Databases, Factual | 17 | 2025 | 1224 | 0.770 |
Why?
|
| Acute Kidney Injury | 5 | 2023 | 685 | 0.760 |
Why?
|
| Computer Simulation | 1 | 2026 | 680 | 0.760 |
Why?
|
| Infarction | 2 | 2020 | 20 | 0.760 |
Why?
|
| Length of Stay | 19 | 2024 | 1398 | 0.750 |
Why?
|
| Intracranial Aneurysm | 1 | 2023 | 83 | 0.740 |
Why?
|
| Intraoperative Complications | 5 | 2023 | 155 | 0.740 |
Why?
|
| Education, Medical, Graduate | 2 | 2024 | 554 | 0.740 |
Why?
|
| Incidence | 18 | 2025 | 3349 | 0.730 |
Why?
|
| Prosthesis Failure | 11 | 2021 | 148 | 0.720 |
Why?
|
| Vascular Access Devices | 5 | 2018 | 34 | 0.710 |
Why?
|
| Median Arcuate Ligament Syndrome | 2 | 2020 | 5 | 0.700 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 180 | 0.690 |
Why?
|
| Stroke | 10 | 2023 | 1050 | 0.690 |
Why?
|
| Atherosclerosis | 8 | 2022 | 949 | 0.690 |
Why?
|
| Operative Time | 9 | 2021 | 207 | 0.650 |
Why?
|
| Adult | 64 | 2025 | 31269 | 0.640 |
Why?
|
| Solitary Kidney | 1 | 2020 | 2 | 0.640 |
Why?
|
| Decompression, Surgical | 1 | 2020 | 88 | 0.640 |
Why?
|
| Catheterization | 3 | 2019 | 232 | 0.620 |
Why?
|
| Follow-Up Studies | 21 | 2020 | 5230 | 0.620 |
Why?
|
| Frailty | 1 | 2022 | 140 | 0.610 |
Why?
|
| Laparoscopy | 3 | 2020 | 552 | 0.610 |
Why?
|
| Embolic Protection Devices | 4 | 2018 | 8 | 0.600 |
Why?
|
| Embolism | 4 | 2018 | 39 | 0.600 |
Why?
|
| Catheters | 4 | 2020 | 84 | 0.600 |
Why?
|
| Kidney Diseases | 6 | 2021 | 472 | 0.600 |
Why?
|
| Predictive Value of Tests | 20 | 2025 | 2307 | 0.590 |
Why?
|
| Endarterectomy | 5 | 2015 | 26 | 0.590 |
Why?
|
| Registries | 16 | 2025 | 1599 | 0.590 |
Why?
|
| Sarcopenia | 1 | 2019 | 56 | 0.590 |
Why?
|
| Publishing | 1 | 2020 | 107 | 0.580 |
Why?
|
| Blood Transfusion | 2 | 2020 | 291 | 0.580 |
Why?
|
| Foot | 1 | 2019 | 61 | 0.580 |
Why?
|
| Thrombosis | 6 | 2019 | 499 | 0.570 |
Why?
|
| Mesentery | 5 | 2012 | 26 | 0.570 |
Why?
|
| Metals | 2 | 2023 | 66 | 0.570 |
Why?
|
| Angiography | 12 | 2018 | 187 | 0.560 |
Why?
|
| Neurofibromatosis 1 | 2 | 2010 | 71 | 0.550 |
Why?
|
| Recurrence | 18 | 2020 | 1478 | 0.530 |
Why?
|
| Paraplegia | 5 | 2022 | 87 | 0.510 |
Why?
|
| Physician's Role | 1 | 2018 | 165 | 0.510 |
Why?
|
| Laparotomy | 1 | 2018 | 140 | 0.510 |
Why?
|
| Spinal Cord | 1 | 2018 | 264 | 0.510 |
Why?
|
| Carotid Artery Diseases | 3 | 2010 | 132 | 0.510 |
Why?
|
| Intermittent Claudication | 6 | 2021 | 49 | 0.500 |
Why?
|
| Constriction, Pathologic | 10 | 2020 | 229 | 0.490 |
Why?
|
| Practice Management, Medical | 1 | 2015 | 8 | 0.450 |
Why?
|
| Survival Rate | 12 | 2020 | 2145 | 0.450 |
Why?
|
| Electrosurgery | 2 | 2025 | 17 | 0.450 |
Why?
|
| Disease Progression | 13 | 2021 | 2202 | 0.440 |
Why?
|
| Vascular Calcification | 2 | 2013 | 70 | 0.440 |
Why?
|
| Lower Extremity | 5 | 2020 | 183 | 0.430 |
Why?
|
| Femoral Vein | 4 | 2020 | 48 | 0.430 |
Why?
|
| Thoracic Vertebrae | 1 | 2014 | 67 | 0.430 |
Why?
|
| Iliac Vein | 4 | 2012 | 28 | 0.430 |
Why?
|
| Spinal Fractures | 1 | 2014 | 46 | 0.420 |
Why?
|
| Chi-Square Distribution | 15 | 2016 | 567 | 0.420 |
Why?
|
| Specialties, Surgical | 3 | 2020 | 90 | 0.420 |
Why?
|
| Models, Biological | 1 | 2019 | 1391 | 0.420 |
Why?
|
| Vascular Fistula | 2 | 2012 | 28 | 0.420 |
Why?
|
| Health Status Disparities | 4 | 2021 | 276 | 0.420 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 108 | 0.410 |
Why?
|
| History, 21st Century | 4 | 2025 | 255 | 0.410 |
Why?
|
| Disease-Free Survival | 9 | 2018 | 904 | 0.410 |
Why?
|
| Aortic Coarctation | 3 | 2022 | 98 | 0.410 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2013 | 20 | 0.410 |
Why?
|
| Ischemic Attack, Transient | 4 | 2022 | 59 | 0.390 |
Why?
|
| Renal Veins | 5 | 2015 | 31 | 0.390 |
Why?
|
| Elective Surgical Procedures | 11 | 2021 | 157 | 0.390 |
Why?
|
| Societies, Medical | 4 | 2025 | 794 | 0.380 |
Why?
|
| Atherectomy | 1 | 2012 | 11 | 0.380 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2025 | 772 | 0.380 |
Why?
|
| History, 20th Century | 3 | 2025 | 360 | 0.370 |
Why?
|
| Collagen Type III | 3 | 2019 | 23 | 0.360 |
Why?
|
| Acute Disease | 7 | 2026 | 1152 | 0.350 |
Why?
|
| Radiography | 6 | 2012 | 739 | 0.350 |
Why?
|
| Regional Blood Flow | 8 | 2019 | 195 | 0.350 |
Why?
|
| Evidence-Based Medicine | 7 | 2020 | 643 | 0.350 |
Why?
|
| Brazil | 3 | 2021 | 117 | 0.350 |
Why?
|
| Odds Ratio | 9 | 2020 | 1231 | 0.350 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2018 | 116 | 0.340 |
Why?
|
| Healthcare Disparities | 3 | 2021 | 505 | 0.340 |
Why?
|
| Punctures | 5 | 2025 | 60 | 0.340 |
Why?
|
| Venous Insufficiency | 2 | 2020 | 6 | 0.330 |
Why?
|
| Hypertension | 3 | 2022 | 1356 | 0.330 |
Why?
|
| Models, Anatomic | 2 | 2024 | 106 | 0.330 |
Why?
|
| Brachiocephalic Trunk | 1 | 2010 | 35 | 0.330 |
Why?
|
| Psoas Muscles | 2 | 2020 | 7 | 0.320 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 56 | 0.310 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 2 | 2015 | 7 | 0.310 |
Why?
|
| Rifampin | 1 | 2011 | 122 | 0.310 |
Why?
|
| Renal Nutcracker Syndrome | 3 | 2015 | 5 | 0.310 |
Why?
|
| Watchful Waiting | 3 | 2021 | 73 | 0.310 |
Why?
|
| Multicenter Studies as Topic | 4 | 2025 | 297 | 0.310 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 201 | 0.310 |
Why?
|
| Hypertension, Renovascular | 3 | 2022 | 28 | 0.310 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 2 | 2020 | 14 | 0.310 |
Why?
|
| Equipment Design | 5 | 2020 | 547 | 0.300 |
Why?
|
| Obesity | 1 | 2020 | 2389 | 0.290 |
Why?
|
| American Heart Association | 4 | 2023 | 324 | 0.290 |
Why?
|
| Carotid Arteries | 3 | 2020 | 126 | 0.290 |
Why?
|
| Time-to-Treatment | 3 | 2020 | 213 | 0.280 |
Why?
|
| Survival Analysis | 5 | 2019 | 1512 | 0.280 |
Why?
|
| Aneurysm, Infected | 3 | 2004 | 24 | 0.280 |
Why?
|
| Heart Transplantation | 1 | 2015 | 832 | 0.280 |
Why?
|
| Young Adult | 20 | 2025 | 10021 | 0.280 |
Why?
|
| Varicose Veins | 2 | 2020 | 27 | 0.270 |
Why?
|
| Syndrome | 3 | 2020 | 1161 | 0.270 |
Why?
|
| Carotid Artery, Common | 2 | 2011 | 60 | 0.270 |
Why?
|
| Multivariate Analysis | 10 | 2021 | 1388 | 0.270 |
Why?
|
| Polytetrafluoroethylene | 3 | 2015 | 62 | 0.270 |
Why?
|
| Cardiology | 2 | 2023 | 511 | 0.260 |
Why?
|
| Magnetic Resonance Angiography | 6 | 2026 | 167 | 0.260 |
Why?
|
| Clinical Trials as Topic | 3 | 2026 | 1131 | 0.260 |
Why?
|
| Proportional Hazards Models | 12 | 2018 | 1408 | 0.260 |
Why?
|
| Hemostatic Techniques | 2 | 2025 | 26 | 0.260 |
Why?
|
| Comorbidity | 9 | 2021 | 1595 | 0.260 |
Why?
|
| Veins | 4 | 2017 | 97 | 0.260 |
Why?
|
| Ultrasonography, Interventional | 3 | 2020 | 207 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 379 | 0.250 |
Why?
|
| Asymptomatic Diseases | 5 | 2019 | 77 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2009 | 1247 | 0.250 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3823 | 0.250 |
Why?
|
| Venous Thrombosis | 2 | 2010 | 169 | 0.250 |
Why?
|
| Abdomen | 2 | 2022 | 130 | 0.250 |
Why?
|
| Aneurysm, Ruptured | 6 | 2015 | 34 | 0.240 |
Why?
|
| Treatment Failure | 4 | 2020 | 350 | 0.240 |
Why?
|
| Mesenteric Veins | 2 | 2017 | 14 | 0.240 |
Why?
|
| Splanchnic Circulation | 4 | 2020 | 49 | 0.240 |
Why?
|
| Endpoint Determination | 1 | 2026 | 57 | 0.240 |
Why?
|
| Fluoroscopy | 2 | 2024 | 101 | 0.240 |
Why?
|
| Vascular Closure Devices | 1 | 2025 | 9 | 0.230 |
Why?
|
| Intestines | 1 | 2010 | 590 | 0.230 |
Why?
|
| Carotid Body Tumor | 2 | 2017 | 5 | 0.230 |
Why?
|
| Patient Discharge | 4 | 2023 | 511 | 0.230 |
Why?
|
| Device Removal | 4 | 2019 | 224 | 0.230 |
Why?
|
| Failure to Rescue, Health Care | 1 | 2025 | 11 | 0.230 |
Why?
|
| Tibial Arteries | 1 | 2005 | 8 | 0.220 |
Why?
|
| Cerebrovascular Disorders | 2 | 2019 | 113 | 0.220 |
Why?
|
| Aerospace Medicine | 1 | 2025 | 37 | 0.220 |
Why?
|
| Vena Cava, Inferior | 3 | 2012 | 95 | 0.220 |
Why?
|
| Limb Salvage | 8 | 2020 | 148 | 0.210 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 2015 | 66 | 0.210 |
Why?
|
| Marfan Syndrome | 2 | 2023 | 146 | 0.210 |
Why?
|
| Prognosis | 7 | 2021 | 4934 | 0.210 |
Why?
|
| Astronauts | 1 | 2025 | 76 | 0.210 |
Why?
|
| Clinical Protocols | 1 | 2025 | 226 | 0.210 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2024 | 274 | 0.210 |
Why?
|
| Intraoperative Care | 2 | 2020 | 121 | 0.210 |
Why?
|
| Fibromuscular Dysplasia | 2 | 2014 | 6 | 0.210 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 318 | 0.210 |
Why?
|
| Wound Healing | 3 | 2025 | 476 | 0.210 |
Why?
|
| Hepatic Artery | 3 | 2016 | 45 | 0.200 |
Why?
|
| Editorial Policies | 1 | 2024 | 48 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 4 | 2013 | 2550 | 0.200 |
Why?
|
| Severity of Illness Index | 7 | 2014 | 3062 | 0.200 |
Why?
|
| Anastomosis, Surgical | 2 | 2019 | 173 | 0.200 |
Why?
|
| Iatrogenic Disease | 1 | 2004 | 120 | 0.200 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 32 | 0.200 |
Why?
|
| Ankle Brachial Index | 3 | 2018 | 41 | 0.190 |
Why?
|
| Anticoagulants | 3 | 2024 | 600 | 0.190 |
Why?
|
| Logistic Models | 11 | 2017 | 1824 | 0.190 |
Why?
|
| Collateral Circulation | 3 | 2018 | 41 | 0.190 |
Why?
|
| Adolescent | 17 | 2024 | 20832 | 0.190 |
Why?
|
| Delphi Technique | 1 | 2024 | 266 | 0.190 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2024 | 231 | 0.190 |
Why?
|
| Electroencephalography | 2 | 2020 | 861 | 0.180 |
Why?
|
| Hemorrhage | 1 | 2025 | 498 | 0.180 |
Why?
|
| Endoscopy | 2 | 2018 | 272 | 0.180 |
Why?
|
| Foreign-Body Migration | 2 | 2013 | 58 | 0.180 |
Why?
|
| Space Flight | 1 | 2025 | 169 | 0.180 |
Why?
|
| Cohort Studies | 8 | 2023 | 5089 | 0.170 |
Why?
|
| Postoperative Hemorrhage | 2 | 2019 | 81 | 0.170 |
Why?
|
| Vascular Malformations | 2 | 2015 | 109 | 0.170 |
Why?
|
| Eye Diseases | 1 | 2002 | 108 | 0.170 |
Why?
|
| Reperfusion | 1 | 2021 | 26 | 0.170 |
Why?
|
| Surgical Flaps | 1 | 2002 | 182 | 0.160 |
Why?
|
| Splenic Artery | 2 | 2022 | 24 | 0.160 |
Why?
|
| Statistics, Nonparametric | 3 | 2012 | 430 | 0.160 |
Why?
|
| Quadriplegia | 1 | 2020 | 35 | 0.160 |
Why?
|
| Switzerland | 1 | 2020 | 15 | 0.160 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2020 | 14 | 0.160 |
Why?
|
| Tantalum | 1 | 2020 | 8 | 0.160 |
Why?
|
| Polyvinyls | 1 | 2020 | 12 | 0.160 |
Why?
|
| Rupture, Spontaneous | 1 | 2020 | 48 | 0.160 |
Why?
|
| Succinate Dehydrogenase | 1 | 2020 | 12 | 0.160 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2020 | 11 | 0.160 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2020 | 4 | 0.160 |
Why?
|
| Portal Vein | 2 | 2015 | 88 | 0.160 |
Why?
|
| Remission, Spontaneous | 1 | 2020 | 63 | 0.160 |
Why?
|
| International Cooperation | 1 | 2020 | 156 | 0.150 |
Why?
|
| Cranial Nerve Injuries | 2 | 2017 | 5 | 0.150 |
Why?
|
| Replantation | 1 | 2020 | 52 | 0.150 |
Why?
|
| Perfusion | 1 | 2021 | 212 | 0.150 |
Why?
|
| Sex Factors | 6 | 2021 | 1341 | 0.150 |
Why?
|
| Pancreatectomy | 1 | 2020 | 147 | 0.150 |
Why?
|
| Thoracic Wall | 1 | 2019 | 41 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2024 | 1462 | 0.150 |
Why?
|
| Neck | 1 | 2020 | 143 | 0.150 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2018 | 16 | 0.150 |
Why?
|
| Thrombectomy | 1 | 2020 | 109 | 0.150 |
Why?
|
| Mesenteric Cyst | 1 | 1998 | 2 | 0.150 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 140 | 0.140 |
Why?
|
| Frail Elderly | 1 | 2019 | 107 | 0.140 |
Why?
|
| Nephrectomy | 1 | 2020 | 157 | 0.140 |
Why?
|
| Circle of Willis | 1 | 2018 | 2 | 0.140 |
Why?
|
| Combined Modality Therapy | 4 | 2012 | 1236 | 0.140 |
Why?
|
| Research | 1 | 2020 | 266 | 0.140 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 218 | 0.140 |
Why?
|
| Renal Insufficiency | 2 | 2019 | 250 | 0.140 |
Why?
|
| Preoperative Care | 3 | 2018 | 355 | 0.140 |
Why?
|
| Data Mining | 1 | 2018 | 66 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 141 | 0.140 |
Why?
|
| Mutation | 3 | 2020 | 6145 | 0.140 |
Why?
|
| Laser Therapy | 1 | 2020 | 239 | 0.140 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 97 | 0.140 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 86 | 0.140 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2018 | 89 | 0.140 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2018 | 38 | 0.140 |
Why?
|
| Body Composition | 1 | 2020 | 548 | 0.130 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 1002 | 0.130 |
Why?
|
| Coronary Artery Bypass | 1 | 2001 | 517 | 0.130 |
Why?
|
| Peritoneovenous Shunt | 1 | 2017 | 4 | 0.130 |
Why?
|
| Chylous Ascites | 1 | 2017 | 9 | 0.130 |
Why?
|
| Middle Cerebral Artery | 1 | 2018 | 115 | 0.130 |
Why?
|
| Patient Admission | 1 | 2018 | 184 | 0.130 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 788 | 0.130 |
Why?
|
| Tomography, Spiral Computed | 1 | 2017 | 14 | 0.130 |
Why?
|
| Catheter Ablation | 1 | 2020 | 318 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2013 | 3869 | 0.130 |
Why?
|
| Colon | 1 | 2020 | 356 | 0.130 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2021 | 195 | 0.130 |
Why?
|
| Streptococcal Infections | 2 | 2013 | 252 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 426 | 0.120 |
Why?
|
| Europe | 3 | 2025 | 368 | 0.120 |
Why?
|
| Health Status | 1 | 2018 | 385 | 0.120 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2015 | 14 | 0.120 |
Why?
|
| Duodenum | 1 | 2016 | 112 | 0.120 |
Why?
|
| Popliteal Vein | 1 | 2015 | 7 | 0.110 |
Why?
|
| Physicians | 1 | 2022 | 636 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 364 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.110 |
Why?
|
| Nerve Compression Syndromes | 1 | 2015 | 14 | 0.110 |
Why?
|
| Biomedical Engineering | 1 | 2015 | 21 | 0.110 |
Why?
|
| Axilla | 1 | 2015 | 43 | 0.110 |
Why?
|
| Motorcycles | 1 | 2014 | 9 | 0.110 |
Why?
|
| Algorithms | 2 | 2018 | 1677 | 0.110 |
Why?
|
| Constriction | 2 | 2013 | 47 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 485 | 0.110 |
Why?
|
| Radiology, Interventional | 1 | 2015 | 35 | 0.110 |
Why?
|
| Fracture Fixation | 1 | 2014 | 29 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2018 | 811 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 471 | 0.110 |
Why?
|
| Netherlands | 2 | 2024 | 54 | 0.110 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 564 | 0.110 |
Why?
|
| Age Factors | 5 | 2021 | 2849 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2016 | 946 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2020 | 560 | 0.110 |
Why?
|
| Writing | 1 | 2015 | 59 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2019 | 54 | 0.100 |
Why?
|
| Athletic Injuries | 1 | 2015 | 69 | 0.100 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2007 | 74 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 105 | 0.100 |
Why?
|
| Device Approval | 2 | 2014 | 12 | 0.100 |
Why?
|
| Awards and Prizes | 1 | 2015 | 61 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2020 | 636 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 743 | 0.100 |
Why?
|
| Stomach | 1 | 2016 | 271 | 0.100 |
Why?
|
| Phlebography | 4 | 2015 | 43 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 234 | 0.100 |
Why?
|
| Tennessee | 1 | 2013 | 34 | 0.100 |
Why?
|
| Cryopreservation | 1 | 2013 | 77 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1158 | 0.100 |
Why?
|
| Living Donors | 1 | 2013 | 112 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2013 | 31 | 0.090 |
Why?
|
| Guanine | 2 | 2023 | 65 | 0.090 |
Why?
|
| Hemangiosarcoma | 1 | 2013 | 46 | 0.090 |
Why?
|
| Oximetry | 1 | 2013 | 177 | 0.090 |
Why?
|
| Ureteral Diseases | 1 | 2012 | 2 | 0.090 |
Why?
|
| Urinary Fistula | 1 | 2012 | 14 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 544 | 0.090 |
Why?
|
| Blood Flow Velocity | 2 | 2023 | 424 | 0.090 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2011 | 16 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 942 | 0.090 |
Why?
|
| Heart Neoplasms | 1 | 2013 | 107 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 270 | 0.090 |
Why?
|
| Tertiary Care Centers | 3 | 2017 | 249 | 0.090 |
Why?
|
| Arteriovenous Fistula | 1 | 2011 | 54 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2021 | 1220 | 0.080 |
Why?
|
| Spinal Cord Diseases | 1 | 2011 | 33 | 0.080 |
Why?
|
| Time | 1 | 2011 | 94 | 0.080 |
Why?
|
| Alloys | 1 | 2010 | 17 | 0.080 |
Why?
|
| Omentum | 1 | 2011 | 39 | 0.080 |
Why?
|
| Heart Arrest, Induced | 1 | 2011 | 74 | 0.080 |
Why?
|
| Dissection | 1 | 2011 | 58 | 0.080 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2011 | 132 | 0.080 |
Why?
|
| Survivors | 1 | 2013 | 348 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2016 | 704 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 2937 | 0.080 |
Why?
|
| Polyesters | 1 | 2009 | 38 | 0.080 |
Why?
|
| Vasculitis | 1 | 2010 | 46 | 0.080 |
Why?
|
| Neoplasms | 2 | 2017 | 2956 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2011 | 145 | 0.080 |
Why?
|
| Cause of Death | 3 | 2018 | 512 | 0.080 |
Why?
|
| Hypothermia, Induced | 1 | 2011 | 175 | 0.080 |
Why?
|
| Lymphatic Vessels | 1 | 2009 | 33 | 0.080 |
Why?
|
| Capillaries | 1 | 2009 | 65 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2013 | 1342 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2013 | 443 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2013 | 356 | 0.070 |
Why?
|
| Dilatation, Pathologic | 2 | 2021 | 79 | 0.070 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 440 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2017 | 974 | 0.070 |
Why?
|
| Child | 7 | 2023 | 26214 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 565 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2020 | 443 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 748 | 0.070 |
Why?
|
| Hernia, Inguinal | 1 | 2007 | 39 | 0.070 |
Why?
|
| Renal Dialysis | 3 | 2019 | 949 | 0.070 |
Why?
|
| Pregnancy | 3 | 2023 | 7499 | 0.060 |
Why?
|
| Hospitalization | 1 | 2016 | 1934 | 0.060 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2019 | 46 | 0.060 |
Why?
|
| Rupture | 1 | 2005 | 34 | 0.060 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2025 | 17 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2099 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2005 | 57 | 0.060 |
Why?
|
| Thrombolytic Therapy | 2 | 2020 | 207 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2011 | 3418 | 0.060 |
Why?
|
| Emergencies | 3 | 2014 | 178 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2006 | 237 | 0.050 |
Why?
|
| Hospitals, High-Volume | 2 | 2016 | 42 | 0.050 |
Why?
|
| Injury Severity Score | 1 | 2025 | 235 | 0.050 |
Why?
|
| Biomarkers | 3 | 2019 | 3400 | 0.050 |
Why?
|
| Listeriosis | 1 | 2004 | 20 | 0.050 |
Why?
|
| Salmonella Infections | 1 | 2004 | 31 | 0.050 |
Why?
|
| Research Design | 1 | 2008 | 718 | 0.050 |
Why?
|
| Leg | 1 | 2005 | 121 | 0.050 |
Why?
|
| Multidetector Computed Tomography | 2 | 2014 | 33 | 0.050 |
Why?
|
| Haemophilus Infections | 1 | 2004 | 97 | 0.050 |
Why?
|
| Thoracic Injuries | 1 | 2024 | 84 | 0.050 |
Why?
|
| Organophosphorus Compounds | 1 | 2023 | 26 | 0.050 |
Why?
|
| Decision Support Techniques | 2 | 2017 | 297 | 0.050 |
Why?
|
| Durable Medical Equipment | 1 | 2002 | 4 | 0.050 |
Why?
|
| Pectoralis Muscles | 1 | 2002 | 5 | 0.050 |
Why?
|
| Neck Dissection | 1 | 2002 | 29 | 0.050 |
Why?
|
| Aspirin | 1 | 2024 | 216 | 0.050 |
Why?
|
| Propensity Score | 2 | 2015 | 266 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2019 | 15011 | 0.050 |
Why?
|
| Research Report | 1 | 2022 | 71 | 0.050 |
Why?
|
| Universities | 1 | 2022 | 123 | 0.050 |
Why?
|
| Escherichia coli Infections | 1 | 2004 | 194 | 0.050 |
Why?
|
| North America | 1 | 2022 | 259 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 1896 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2015 | 301 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 539 | 0.040 |
Why?
|
| Aftercare | 1 | 2022 | 153 | 0.040 |
Why?
|
| Brachiocephalic Veins | 1 | 2000 | 12 | 0.040 |
Why?
|
| Subclavian Vein | 1 | 2000 | 19 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2024 | 1164 | 0.040 |
Why?
|
| Critical Illness | 2 | 2016 | 615 | 0.040 |
Why?
|
| Life Tables | 2 | 2016 | 26 | 0.040 |
Why?
|
| Heel | 1 | 2000 | 9 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 43 | 0.040 |
Why?
|
| Prevalence | 1 | 2007 | 2684 | 0.040 |
Why?
|
| Foot Ulcer | 1 | 2000 | 19 | 0.040 |
Why?
|
| Biopsy | 2 | 2015 | 1241 | 0.040 |
Why?
|
| Suction | 1 | 2020 | 50 | 0.040 |
Why?
|
| France | 1 | 2019 | 90 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 56 | 0.040 |
Why?
|
| Italy | 1 | 2019 | 111 | 0.040 |
Why?
|
| Lung Diseases | 2 | 2017 | 403 | 0.040 |
Why?
|
| Troponin | 1 | 2019 | 69 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 364 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 326 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2020 | 219 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 278 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 144 | 0.040 |
Why?
|
| Death Certificates | 1 | 2018 | 10 | 0.040 |
Why?
|
| Tobacco Use Disorder | 1 | 2019 | 90 | 0.040 |
Why?
|
| Poland | 1 | 2018 | 55 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2020 | 141 | 0.030 |
Why?
|
| Infant | 2 | 2019 | 13323 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 107 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2017 | 48 | 0.030 |
Why?
|
| Hong Kong | 1 | 2017 | 21 | 0.030 |
Why?
|
| Colombia | 1 | 2017 | 49 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2017 | 21 | 0.030 |
Why?
|
| Skull Base | 1 | 2017 | 48 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.030 |
Why?
|
| Mexico | 1 | 2017 | 186 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 240 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 239 | 0.030 |
Why?
|
| Smoking | 1 | 2021 | 926 | 0.030 |
Why?
|
| Ligation | 1 | 2016 | 133 | 0.030 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2015 | 35 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2015 | 29 | 0.030 |
Why?
|
| Liver Circulation | 1 | 2015 | 19 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2018 | 216 | 0.030 |
Why?
|
| Global Health | 1 | 2020 | 626 | 0.030 |
Why?
|
| Creatinine | 1 | 2017 | 397 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2015 | 131 | 0.030 |
Why?
|
| Ohio | 1 | 2014 | 88 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1000 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 934 | 0.030 |
Why?
|
| Buttocks | 1 | 2014 | 5 | 0.030 |
Why?
|
| Colitis, Ischemic | 1 | 2014 | 3 | 0.030 |
Why?
|
| Physical Examination | 1 | 2015 | 162 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2014 | 63 | 0.030 |
Why?
|
| Second-Look Surgery | 1 | 2013 | 4 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2013 | 31 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2014 | 125 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 142 | 0.020 |
Why?
|
| Pericardiectomy | 1 | 2013 | 9 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 1272 | 0.020 |
Why?
|
| Renal Circulation | 1 | 2013 | 41 | 0.020 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2013 | 13 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 130 | 0.020 |
Why?
|
| Cardiac Tamponade | 1 | 2013 | 37 | 0.020 |
Why?
|
| Allografts | 1 | 2013 | 216 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2017 | 502 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 155 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2013 | 317 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2013 | 156 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 301 | 0.020 |
Why?
|
| Age Distribution | 1 | 2013 | 426 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 1086 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2013 | 90 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 273 | 0.020 |
Why?
|
| Cystoscopy | 1 | 2012 | 41 | 0.020 |
Why?
|
| Pericardium | 1 | 2013 | 104 | 0.020 |
Why?
|
| Dyspnea | 1 | 2013 | 160 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 220 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2013 | 297 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 393 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 615 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 4039 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 692 | 0.020 |
Why?
|
| Heart Failure | 1 | 2023 | 2317 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2013 | 316 | 0.020 |
Why?
|
| Takayasu Arteritis | 1 | 2010 | 12 | 0.020 |
Why?
|
| Polyarteritis Nodosa | 1 | 2010 | 10 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2013 | 518 | 0.020 |
Why?
|
| Hypotension | 1 | 2011 | 184 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2012 | 401 | 0.020 |
Why?
|
| Lymphography | 1 | 2009 | 10 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4479 | 0.020 |
Why?
|
| Sclerotherapy | 1 | 2009 | 37 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 736 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 2009 | 48 | 0.020 |
Why?
|
| Observation | 1 | 2009 | 39 | 0.020 |
Why?
|
| Weight Loss | 1 | 2013 | 526 | 0.020 |
Why?
|
| Giant Cell Arteritis | 1 | 2010 | 49 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2013 | 637 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2126 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3417 | 0.020 |
Why?
|
| Groin | 1 | 2007 | 14 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 985 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2008 | 85 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2007 | 64 | 0.020 |
Why?
|
| Echocardiography | 1 | 2013 | 1139 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2011 | 768 | 0.020 |
Why?
|
| Warfarin | 1 | 2007 | 123 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2008 | 199 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1299 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 895 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 877 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1175 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 281 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 1538 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 599 | 0.010 |
Why?
|
| Gangrene | 1 | 2000 | 26 | 0.010 |
Why?
|
| Debridement | 1 | 2000 | 87 | 0.010 |
Why?
|
| Graft Survival | 1 | 2000 | 462 | 0.010 |
Why?
|